Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
New movies to watch this weekend: See 'They Will Kill You' in theaters, rent 'Send Help,' stream 'Pretty Lethal' on Prime Video - 2From Sea shores to Urban areas: Astonishing Worldwide Travel Objections
- 3100 new alien worlds: Scientists find hidden haul in data from NASA exoplanet-hunting spacecraft
- 4Bennu asteroid samples provide clues about solar system origins and 'space gum'
- 5Vaccine exemptions for religious or personal beliefs are rising across the U.S.
- Japan deploys the military to counter a surge in bear attacks
- Find the Standards of Powerful Cooperation: Accomplishing Cooperative energy and Coordinated effort
- 5 Chiefs That Changed Our Opinion on Film
- Bonk.fun’s April Fools Joke Targets Israel, Sparks Debate
- Ukraine's naval drones are gunning for Russia's 'shadow fleet.' A security source says a tanker just suffered a critical hit.
- Vietnam rethinks its flood strategy as climate change drives storms and devastation
- Fundamental Home Exercise center Hardware: Amplify Your Exercises
- 7 Odd Apparatuses to Make Your Party Stick Out!
- Arctic sea ice just dropped to an alarming new low
